Skip to Content
You are currently on the new version of our website. Access the old version .
  • Editorial
  • Open Access

13 November 2019

4 Pages

Mucins and Asthma: Are We Headed to the Revolutionary Road?

,
and
1
Department of Biomedical and Clinical Sciences (DIBIC), Division of Respiratory Diseases, Università degli Studi di Milano, Ospedale L. Sacco, ASST Fatebenfratelli-Sacco, Via G.B. Grassi, 74-20157 Milano, Italy
2
SC Anestesia e Rianimazione, Ospedale San Paolo—Polo Universitario, ASST Santi Paolo e Carlo, Dipartimento di Scienze della Salute, Università degli Studi di Milano, Via Antonio di Rudinì, 8-20142 Milano, Italy
3
Centro Ricerca Coordinata di Insufficienza Respiratoria, 20123 Milano, Italy
*
Author to whom correspondence should be addressed.
This article belongs to the Section Respiratory Medicine

Abstract

Mucus represents the first line of defense of our respiratory tract and mucociliary clearance is essential for maintaining the homeostasis of airway epithelium. The latter mechanisms are altered in asthma and mucus plugging of proximal and distal airways is the main cause of death in cases of fatal asthma. Starting from the influential review performed by Luke R. Bonser and David J. Erle in 2017, we discuss the latest evidence in terms of mucins regulation and potential treatment of mucus hypersecretion and tissue remodeling in severe asthma.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.